X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (537) 537
humans (343) 343
animals (291) 291
polyglutamic acid - analogs & derivatives (268) 268
polyglutamic acid - chemistry (239) 239
pharmacology & pharmacy (183) 183
female (180) 180
mice (164) 164
nanoparticles (137) 137
male (136) 136
polyglutamic acid - metabolism (106) 106
polyglutamic acid - therapeutic use (96) 96
poly (95) 95
methotrexate - analogs & derivatives (91) 91
cancer (88) 88
drug delivery systems (87) 87
cell line, tumor (83) 83
materials science, biomaterials (80) 80
glutamate (71) 71
polyglutamic acid - administration & dosage (70) 70
oncology (68) 68
drug carriers - chemistry (67) 67
rats (66) 66
methotrexate (64) 64
nanoparticles - chemistry (64) 64
particle size (64) 64
polymers (64) 64
chemistry, multidisciplinary (61) 61
methotrexate - therapeutic use (61) 61
drug-delivery (60) 60
engineering, biomedical (59) 59
methotrexate - metabolism (55) 55
drugs (52) 52
in-vivo (52) 52
paclitaxel - analogs & derivatives (52) 52
polyglutamic acid - pharmacology (52) 52
cell survival - drug effects (51) 51
middle aged (49) 49
polyethylene glycols - chemistry (49) 49
cells (48) 48
polyglutamic acid (48) 48
polymers - chemistry (48) 48
paclitaxel (47) 47
analysis (45) 45
chemotherapy (45) 45
mice, inbred balb c (45) 45
therapy (45) 45
antineoplastic agents - administration & dosage (44) 44
in-vitro (43) 43
aged (42) 42
antineoplastic agents - therapeutic use (41) 41
biochemistry & molecular biology (41) 41
cell line (41) 41
polyglutamic acid - blood (41) 41
delivery (40) 40
micelles (40) 40
drug delivery (39) 39
adult (38) 38
tumors (38) 38
vehicles (38) 38
amino acids (37) 37
mice, inbred c57bl (36) 36
mice, nude (36) 36
neoplasms - drug therapy (36) 36
toxicity (36) 36
doxorubicin (35) 35
chitosan (34) 34
hydrogen-ion concentration (33) 33
nanoscience & nanotechnology (33) 33
paclitaxel - administration & dosage (33) 33
proteins (33) 33
gene delivery (32) 32
kinetics (32) 32
methotrexate - blood (32) 32
pharmacokinetics (32) 32
polyglutamic acid - pharmacokinetics (32) 32
dose-response relationship, drug (31) 31
glutamic acid (31) 31
article (30) 30
paclitaxel - therapeutic use (30) 30
polyglutamic acid - chemical synthesis (30) 30
tumor (30) 30
arthritis, rheumatoid - drug therapy (29) 29
antineoplastic agents - pharmacology (28) 28
antineoplastic combined chemotherapy protocols - therapeutic use (28) 28
chitosan - chemistry (28) 28
glutaminsäure (28) 28
methotrexate - pharmacokinetics (28) 28
tissue distribution (28) 28
treatment outcome (28) 28
lung neoplasms - drug therapy (27) 27
research (27) 27
acids (26) 26
antirheumatic agents - therapeutic use (26) 26
child (26) 26
cytotoxicity (26) 26
drug carriers (26) 26
drug delivery systems - methods (26) 26
efficacy (26) 26
erythrocytes - metabolism (26) 26
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biomaterials, ISSN 0142-9612, 2011, Volume 32, Issue 15, pp. 3862 - 3874
Abstract Angiogenesis plays a prominent role in cancer progression. Anti-angiogenic therapy therefore, either alone or in combination with conventional... 
Advanced Basic Science | Dentistry | Angiogenesis | Integrin | Polyglutamic acid | Polymer therapeutics | Paclitaxel | RGD peptidomimetic | MATERIALS SCIENCE, BIOMATERIALS | RGD PEPTIDES | ENGINEERING, BIOMEDICAL | PS 2 PATIENTS | BRAIN-TUMORS | CELL LUNG-CANCER | BREAST-CANCER | CONJUGATE | POLIGLUMEX CT-2103 | INHIBITORS | CATHEPSIN-B | Paclitaxel - metabolism | Rats, Wistar | Humans | Polyglutamic Acid - administration & dosage | Integrins - metabolism | Drug Delivery Systems | Polyglutamic Acid - analogs & derivatives | Paclitaxel - chemistry | Antineoplastic Agents, Phytogenic - administration & dosage | Antineoplastic Agents, Phytogenic - metabolism | Antineoplastic Agents, Phytogenic - therapeutic use | Paclitaxel - administration & dosage | Oligopeptides - chemistry | Polyglutamic Acid - metabolism | Paclitaxel - analogs & derivatives | Rats | Antineoplastic Agents, Phytogenic - chemistry | Cathepsin B - metabolism | Oligopeptides - metabolism | Paclitaxel - therapeutic use | Neoplasms - drug therapy | Polyglutamic Acid - chemistry | Animals | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Polyglutamic Acid - therapeutic use | Drugs | Drug delivery systems | Biological products | Endothelial growth factors | Development and progression | Permeability | Antineoplastic agents | Cells | Endothelium | Vehicles | Antimitotic agents | Fibrin | Fibrinogen | Physiological aspects | Polymer industry | Polymers | Vascular endothelial growth factor | Tumors | Integrins | Index Medicus | paclitaxel | polymer therapeutics | integrin
Journal Article
Molecules, ISSN 1420-3049, 10/2018, Volume 23, Issue 10, p. 2565
Journal Article
Nanomedicine: Nanotechnology, Biology, and Medicine, ISSN 1549-9634, 2012, Volume 8, Issue 1, pp. 71 - 80
Abstract The in vivo efficacy of doxorubicin (DOX)-loaded poly(γ-benzyl l -glutamate)- block -hyaluronan (PBLG23 - b -HYA10 )-based polymersomes (PolyDOX) was... 
Internal Medicine | Hyaluronan | Ehrlich ascites tumor (EAT) | Antitumor activity | Doxorubicin | Polymersomes | MEDICINE, RESEARCH & EXPERIMENTAL | BLOCK-COPOLYMERS | SOLID TUMORS | DRUG-DELIVERY | RECEPTOR | NANOSCIENCE & NANOTECHNOLOGY | VASCULAR-PERMEABILITY | CANCER | CARRIERS | PACLITAXEL | LIPOSOMAL DOXORUBICIN | ENDOCYTOSIS HARE | Doxorubicin - blood | Doxorubicin - therapeutic use | Drug Carriers - adverse effects | Hyaluronic Acid - therapeutic use | Nanoparticles - chemistry | Antineoplastic Agents - chemical synthesis | Humans | Drug Carriers - administration & dosage | Polyglutamic Acid - administration & dosage | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Nanoparticles - adverse effects | Drug Carriers - chemistry | Polyglutamic Acid - analogs & derivatives | Antineoplastic Agents - adverse effects | Female | Hyaluronic Acid - blood | Hyaluronic Acid - adverse effects | Doxorubicin - administration & dosage | Endocytosis - immunology | Technetium - chemistry | Rabbits | Hyaluronic Acid - administration & dosage | Hyaluronic Acid - chemistry | Carcinoma, Ehrlich Tumor - drug therapy | Doxorubicin - chemical synthesis | Polyglutamic Acid - blood | Polyglutamic Acid - chemistry | Animals | Hyaluronic Acid - analogs & derivatives | Antineoplastic Agents - blood | Hyaluronan Receptors - immunology | Mice | Mice, Inbred BALB C | Nanoparticles - administration & dosage | Polyglutamic Acid - therapeutic use | Neoplasms, Experimental - drug therapy | Doxorubicin - adverse effects | Polyglutamic Acid - adverse effects | Anthracyclines | Ascites | Hyaluronic acid | Tumors | Index Medicus | Polymers | Chemical Sciences
Journal Article
British Journal of Cancer, ISSN 0007-0920, 05/2008, Volume 98, Issue 10, pp. 1608 - 1613
Journal Article
Journal Article
Journal of Biomedical Materials Research Part A, ISSN 1549-3296, 11/2017, Volume 105, Issue 11, pp. 3006 - 3016
A novel hyaluronan (HA) derivative, poly(L‐glutamic acid)‐grafted hyaluronan (PGA‐g‐HA), was synthesized to improve the durability of conventional HA products... 
poly(L‐glutamic acid) | intra‐articular injection | hyaluronan | cartilage | intra-articular injection | poly(L-glutamic acid) | RHEUMATOID-ARTHRITIS | MATERIALS SCIENCE, BIOMATERIALS | MOLECULAR-WEIGHT | CARTILAGE DEGENERATION | SYNOVIAL-FLUID | ENGINEERING, BIOMEDICAL | CROSS-LINKED HYALURONATE | SODIUM HYALURONATE | TERTIARY STRUCTURES | AQUEOUS-SOLUTION | HYLAN G-F-20 | KNEE OSTEOARTHRITIS | Viscosity | Hyaluronic Acid - therapeutic use | Hyaluronic Acid - administration & dosage | Chondrocytes - immunology | Cells, Cultured | Hyaluronic Acid - chemistry | Elasticity | Male | Polyglutamic Acid - administration & dosage | Rats, Sprague-Dawley | Chondrocytes - drug effects | Polyglutamic Acid - chemistry | Animals | Anti-Inflammatory Agents - chemistry | Injections, Intra-Articular | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Osteoarthritis, Knee - immunology | Polyglutamic Acid - therapeutic use | Osteoarthritis, Knee - drug therapy | Glutamate | Hyaluronic acid | Amino acids | Viscoelasticity | Knee | Glutamic acid | Antiinflammatory agents | Storage modulus | Dendritic cells | Syngeneic grafts | Durability | Knee (anatomy) | Inflammation | Loss modulus | Injection | Grafting | Biological activity | Medicine | Hyaluronan | Biomedical materials | Acids | Immunogenicity | Chondrocytes | Interleukin 1 | Bone marrow | Biocompatibility | Osteoarthritis | Index Medicus
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 06/2008, Volume 3, Issue 6, pp. 623 - 630
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 03/2017, Volume 249, pp. 162 - 172
Journal Article
Journal Article
Journal Article
Journal Article